Researchers Turn to Cloud Computing as Genomic Sequencing Data Threatens to Overwhelm Traditional IT Systems
Seeking Young Scientists for Research in Space
Sounds of Science Podcasts
Tackling the Inevitability of Resistance One Genome at a Time
Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
New Treatments for Alzheimer’s Disease
The global market value of Alzheimer’s disease (AD) therapeutics could soar to the $8 billion range once therapeutics are approved that actually change the course of the disease. More than 150 companies are working on new treatments for AD, including approximately 15 multinationals and 30 generics companies. Which new therapies do you think will be most successful at treating AD?